Selected References
- Askew J, 2007. Zolpidem addiction in pregnant woman with a history of second trimester bleeding. Pharmacotherapy, 27(2):306-308.
- Huitfeldt A, et al. 2020. Associations of maternal use of benzodiazepines or benzodiazepine-like hypnotics during pregnancy with immediate pregnancy outcomes in Norway. JAMA Netw Open, 3(6):e205860.
- Grigoriadis S, et al. 2022. Hypnotic benzodiazepine receptor agonist exposure during pregnancy and the risk of congenital malformations and other adverse pregnancy outcomes: a systematic review and meta-analysis. Acta Psychiatr Scand, 146(4):312‐324.
- Juric S, et al. 2009. Zolpidem in pregnancy: placental passage and outcome. Arch Womens Ment Health, 12:441-446.
- Lupattelli A, et al. 2019. Association of maternal use of benzodiazepines and z-hypnotics during pregnancy with motor and communication skills and attention-deficit/hyperactivity disorder symptoms in preschoolers. JAMA Netw Open, 2(4):e191435.
- Meng L, et al. 2024. Association between maternal benzodiazepine or z-hypnotic use in early pregnancy and the risk of stillbirth, preterm birth, and small for gestational age: a nationwide, population-based cohort study in Taiwan. Epilepsy Currents, 24(2)105-107.
- Pons G, et al. 1989. Zolpidem excretion in breast milk. Eur J Clin Pharmacol, 37:245-248.
- Reichner C. 2015. Insomnia and sleep deficiency in pregnancy. Obstetric Medicine,8(4):168-171.
- Saito J, et al. 2022. Presence of hypnotics in the cord blood and breast milk, with no adverse effects in the infant: a case report. Breastfeeding Med, 17(4):349-352.
- Sundbakk LM, et al. 2022. Association of prenatal exposure to benzodiazepines and z-hypnotics with risk of attention-deficit/hyperactivity disorder in childhood. JAMA Netw Open, 5(12):e2246889.
- Wang LH, et al. 2010. Increased risk of adverse pregnancy outcomes in women receiving zolpidem during pregnancy. Clinical Pharmacology and Therapeutics, 88(3):369-374.
- Wikner BN, Kallen B. 2011. Are hypnotic benzodiazepine receptor agonists teratogenic in humans? Journal of Clinical Psychopharmacology, 31(3):356-359.
